US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

Eczema Lotion Hydrocortisone 1% / Anti-Itch Lotion

Reason CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.

US Pharmaceuticals Inc. NDC 0363-0670-04 D-1725-2019
Class II · Moderate risk Terminated

CVS Health Glycerin Suppositories

Reason CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.

US Pharmaceuticals Inc. D-1724-2019
Class II · Moderate risk Terminated

Hydrocodone Polistirex and Chlorpheniramine Polistirex…

Reason Superpotent Drug and Failed Stability Specifications: High out-of-specification results for the active ingredients, hydrocodone and chlorpheniramine, as well as high out-of-specification results for the preservatives.

Tris Pharma Inc. NDC 27808-086-02 D-1517-2019
Class II · Moderate risk Terminated

Equate Night-time Sleep Aide

Reason Microbial contamination of non-sterile product

LNK International, Inc. NDC 49035-330-02 D-1630-2019
Class II · Moderate risk Terminated

Milrinone Lactate Injection 200 mcg

Reason Lack of Assurance of Sterility: Bags have the potential to leak.

Pfizer Inc. NDC 0409-2776-23 D-1487-2019
Class II · Moderate risk Terminated

Milrinone Lactate Injection 200 mcg

Reason Lack of Assurance of Sterility: Bags have the potential to leak.

Pfizer Inc. NDC 0409-2776-02 D-1486-2019
Class II · Moderate risk Terminated

Gablofen

Reason Failed Impurities/Degradation Specification -This recall is being initiated as a precaution due to the presence of an unknown impurity observed during shelf life of the product.

Piramal Critical Care, Inc. NDC 66794-151-01 D-1742-2019
Class II · Moderate risk Terminated

Kaitlib Fe norethindrone and ethinyl estradiol chewable tablets

Reason Failed Impurities/Degradation Specifications: Kaitlib Fe Tablets has an out of specification result observed in long term stability study.

Lupin Pharmaceuticals Inc. NDC 68180-903-11 D-1565-2019
Class II · Moderate risk Completed

Clear Eyes Redness Relief

Reason Lack of Assurance of Sterility

Altaire Pharmaceuticals, Inc. D-0490-2020
Class II · Moderate risk Completed

Clear Eyes Redness Relief

Reason Lack of Assurance of Sterility

Altaire Pharmaceuticals, Inc. D-0489-2020
Class II · Moderate risk Completed

Clear Eyes Redness Relief

Reason Lack of Assurance of Sterility

Altaire Pharmaceuticals, Inc. D-0487-2020
Class II · Moderate risk Completed

FreshKote Lubricant Eye Drops

Reason Lack of Assurance of Sterility

Altaire Pharmaceuticals, Inc. NDC 15821-101-15 D-0483-2020
Class II · Moderate risk Completed

Puralube Ophthalmic Ointment

Reason Lack of Assurance of Sterility

Altaire Pharmaceuticals, Inc. NDC 0574-4025-20 D-0474-2020